1. Home
  2. BNR vs BSL Comparison

BNR vs BSL Comparison

Compare BNR & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$8.62

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Logo Blackstone

BSL

Blackstone

HOLD

Current Price

$12.98

Market Cap

172.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
BSL
Founded
2014
2010
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
172.0M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
BSL
Price
$8.62
$12.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.5K
38.0K
Earning Date
06-05-2026
01-01-0001
Dividend Yield
N/A
9.55%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$12.45
52 Week High
$41.72
$14.35

Technical Indicators

Market Signals
Indicator
BNR
BSL
Relative Strength Index (RSI) 28.99 46.84
Support Level $8.04 $12.82
Resistance Level $9.70 $13.33
Average True Range (ATR) 1.17 0.09
MACD -0.06 0.00
Stochastic Oscillator 7.02 65.44

Price Performance

Historical Comparison
BNR
BSL

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About BSL Blackstone

Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The fund also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.

Share on Social Networks: